Best of Both (BOB) Trial: A Feasibility Study of Hybrid High Dose Rate Brachytherapy and Stereotactic Ablative Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2026
This article has no abstract
Epistemonikos ID: 31c523156b8df3d786a9255b5c459e3a0a7a99fe
First added on: Oct 29, 2026